APOE and Myocardial fibrosis: We have previously shown that platelet accumulation in atherosclerotic coronary arteries and myocardial fibrosis were both reduced in SR-B1/apoE dKO mice treated with the hydroxymethylglutaryl coenzyme A reductase inhibitor, rosuvastatin (Yu et al., 2018b).